Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis

BACKGROUND: Treatment with tumor necrosis factor inhibitors for rheumatoid arthritis has been associated with a decreased risk of cardiovascular disease in observational studies. There are conflicting data on the influence of tumor necrosis factor inhibitors on lipid levels. OBJECTIVES: To evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergström, Ulf, Jovinge, Stefan, Persson, Jerker, Jacobsson, Lennart T.H., Turesson, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097545/
https://www.ncbi.nlm.nih.gov/pubmed/30128057
http://dx.doi.org/10.1016/j.curtheres.2018.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097545/
https://www.ncbi.nlm.nih.gov/pubmed/30128057
http://dx.doi.org/10.1016/j.curtheres.2018.07.001

Ejemplares similares